enVVeno Medical Corporation (NVNO)
NASDAQ
6.65
-0.26 (-3.76%)
Closed
Oct 23, 2026
Day's Range
6.556.76
52 wk Range
6.5526.70
Financial Statements - NVNO - enVVeno Medical Corporation
Revenue
0
Net Income
-19.47M▲ 10.8%
EBITDA
-21.14M▲ 15.1%
Free Cash Flow
-15.57M▲ 7.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -20.89M | -23.82M | -25.23M | -24.93M | -16.89M | -9.13M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 735K | 1.61M | 1.54M | 102K | 346K | -4.09K |
| Pre Tax Income | -19.47M | -21.81M | -23.51M | -24.66M | -16.52M | -9.13M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -19.47M | -21.81M | -23.51M | -24.66M | -16.52M | -9.13M |
| EPS Basic | -33.059985 | -44.45 | -1.91 | -2.2 | -1.9 | -7.54 |
| EPS Diluted | -33.059985 | -44.45 | -1.91 | -2.2 | -1.9 | -7.54 |
| Basic Shares Outstanding | 588.99K | 489.77K | 12.30M | 11.23M | 8.68M | 1.29M |
| Diluted Shares Outstanding | 588.99K | 489.77K | 12.30M | 11.23M | 8.68M | 1.29M |
| Ebit | -20.89M | -23.82M | -25.23M | -24.93M | -16.89M | -9.13M |
| Ebitda | -21.14M | -24.91M | -26.23M | -24.50M | -16.75M | -8.96M |
| Net Income Continuous Operations | -19.47M | -21.81M | -23.51M | -24.66M | -16.52M | -9.13M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
